Sustained Virologic Response, Pharmacogenomic and Biopsy Analysis of HCV Patients Receiving GI-5005 Therapeutic Vaccine to be Presented at the Annual Meeting of the European Association for the Study of the Liver LOUISVILLE, Colo., March 17, 2010 – GlobeImmune Inc. today … Continue reading
GlobeImmune Announces Presentations of GI-5005 Phase 2b Data at EASL 2010 Meeting
March 17, 2010